Onychomycosis, also known as tinea unguium, is a fungal infection of the nail. Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. Toenails or fingernails may be affected, but it is more common for toenails to be affected. Complications may include cellulitis of the lower leg.
Onychomycosis occurs in about 10 percent of the adult population. Older people are more frequently affected. Males are affected more often than females. Onychomycosis represents about half of nail disease.

Market Analysis and Insights: Global Onychomycosis Market
The global Onychomycosis market size is projected to reach US$ 14900 million by 2027, from US$ 9414.9 million in 2020, at a CAGR of 6.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Onychomycosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Onychomycosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Onychomycosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Onychomycosis market.

Global Onychomycosis Scope and Market Size
Onychomycosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Onychomycosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Distal Subungual Onychomycosis
White Superficial Onychomycosis
Proximal Subungual Onychomycosis
Candida Onychomycosis
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Glaxosmithkline
Pfizer
Bausch Health
Galderma
Janssen Biotech
Bristol Meyer Squibb
Topica Pharmaceuticals
Sanofi
Novartis